Data as of Dec 06
| +0.86 / +1.65%|
The 13 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 52.00, with a high estimate of 60.00 and a low estimate of 41.00. The median estimate represents a -1.74% decrease from the last price of 52.92.
The current consensus among 19 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.